| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/28/2007 | US7262183 Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases |
| 08/28/2007 | US7262182 Sulfonylethyl phosphorodiamidates |
| 08/28/2007 | US7262181 Providing at least one oxidized-etherified cellulose derivative selected from the group consisting of water-soluble methylcellulose, ethylcellulose, hydroxyethylcellulose and salts of carboxymethylcellulose, forming the oxidized-etherified cellulose derivative into the medical and treatment products |
| 08/28/2007 | US7262180 For therapy of dermatitis conditions and skin impairments such as atopic dermatitis, contact dermatitis, allergic contact dermatitis, allergic dermatitis, seborrheic dermatitis, nummular dermatitis, chronic dermatitis of hands or feet, generalized exfoliative dermatitis, stasis dermatitis |
| 08/28/2007 | US7262179 Wound care compositions |
| 08/28/2007 | US7262178 Treatment of sepsis and septic shock |
| 08/28/2007 | US7262177 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use |
| 08/28/2007 | US7262176 useful in the treatment of neurological, cardiac, and other cellular proliferative disorders |
| 08/28/2007 | US7262175 Anticancer agents; blood disorders |
| 08/28/2007 | US7262173 Chemosensitizing with liposomes containing oligonucleotides |
| 08/28/2007 | US7262172 Bactericides; therapy for infections |
| 08/28/2007 | US7262171 Applying rhamnolipids for cosmetic treatment of wrinkles |
| 08/28/2007 | US7262170 Pharmaceutical composition for reducing vaginal acidity and treatment of vaginitis, and the use thereof |
| 08/28/2007 | US7262169 Process for preparing peptide intermediates |
| 08/28/2007 | US7262164 Polymeric thiol-linked prodrugs employing benzyl elimination systems |
| 08/28/2007 | US7262052 DNA sequence that encodes a polypeptide that is a voltage activated calcium channel alpha 2 delta -C subunit |
| 08/28/2007 | US7262044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 08/28/2007 | US7262017 Diagnostic markers for ischemia |
| 08/28/2007 | US7261910 Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use |
| 08/28/2007 | US7261909 Producing vegetation water from olives; adding acid; incubating the acidified vegetation water for a period of at least two months, until at least 75% of oleoeuropein has been converted to hydroxytyrosol |
| 08/28/2007 | US7261908 Composition based on natural substances useful in the maintenance of the correct hydration of the skin |
| 08/28/2007 | US7261905 Disinfectant and method of making |
| 08/28/2007 | US7261889 Local anesthetic methods and kits |
| 08/28/2007 | US7261888 Combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements |
| 08/28/2007 | US7261880 Methods of treating Syndrome X with aliphatic polyamines |
| 08/28/2007 | US7261879 Iodinated anion exchange resin and process for preparing same |
| 08/28/2007 | US7261878 Reduction of hair growth |
| 08/28/2007 | US7261769 Stabilized anthocyanin extract from Garcinia indica |
| 08/28/2007 | US7261735 Local drug delivery devices and methods for maintaining the drug coatings thereon |
| 08/28/2007 | CA2638668A1 Methods and compositions for treating fish diseases |
| 08/28/2007 | CA2579758A1 Epimers and isomers of tetrazole containing rapamycin analogs, methods of making and using the same |
| 08/28/2007 | CA2579735A1 Isomers of rapamycin and 42-epi-rapamycin, methods of making and using the same |
| 08/28/2007 | CA2579734A1 Isomers and 42-epimers of rapamycin alkyl ether analogs, methods of making and using the same |
| 08/28/2007 | CA2579731A1 Rapamycin analogs containing an antioxidant moiety |
| 08/28/2007 | CA2579729A1 Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same |
| 08/28/2007 | CA2579699A1 Isomers and 42-epimers of rapamycin ester analogs, methods of making and using the same |
| 08/28/2007 | CA2504078C Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 08/28/2007 | CA2485337C Analgesic composition and method |
| 08/28/2007 | CA2461157C Sustained release heterodisperse hydrogel systems - amorphous drugs |
| 08/28/2007 | CA2405072C Gel compositions containing metronidazole |
| 08/28/2007 | CA2389858C New cyclic derivatives of .alpha.-amino-.gamma.-hydroxy-amides, the process for the preparation thereof and the pharmaceutical compounds which contain them |
| 08/28/2007 | CA2367755C Dimeric compounds and their use as inhibitors of neuraminidase |
| 08/28/2007 | CA2342198C Therapeutic agent for spinal canal stenosis |
| 08/28/2007 | CA2335995C Inhibitors of phosphatidyl myo-inositol cycle |
| 08/28/2007 | CA2311881C Control of arthropods in rodents |
| 08/28/2007 | CA2294515C Eprosartan monohydrate |
| 08/28/2007 | CA2293338C Isomer enriched conjugated linoleic acid compositions |
| 08/28/2007 | CA2290502C Treatment of hepatic cirrhosis |
| 08/28/2007 | CA2278507C Method for treatment of cns-involved lysosomal storage diseases |
| 08/28/2007 | CA2265874C Condensed n-acylindoles as antitumor agents |
| 08/28/2007 | CA2264693C Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 08/28/2007 | CA2257875C Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders |
| 08/28/2007 | CA2247232C Antimicrobial composition |
| 08/28/2007 | CA2230960C Piperazine derivatives and process for the preparation thereof |
| 08/28/2007 | CA2226346C Triterpene derivatives and pharmaceuticals for treating hepatic disorders |
| 08/28/2007 | CA2222103C Inositolglycans having insulin-like action |
| 08/28/2007 | CA2218619C Antibacterial-wound healing compositions and methods for preparing and using same |
| 08/28/2007 | CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 08/28/2007 | CA2193553C Method for treatment of lupus nephritis |
| 08/28/2007 | CA2184727C Proteasome regulation of nf-kb activity |
| 08/28/2007 | CA2177827C Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 08/28/2007 | CA2160243C 36-derivatives of rifamycins and their use as antimicrobial agents |
| 08/28/2007 | CA2148253C Allergenic proteins and peptides from johnson grass pollen |
| 08/28/2007 | CA2072934C Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 08/24/2007 | CA2579477A1 Implantable device formed from polymer and plasticizer blends |
| 08/24/2007 | CA2579324A1 Implantable device formed from polymer blends |
| 08/24/2007 | CA2579250A1 Implantable device prepared from solution processing |
| 08/24/2007 | CA2579193A1 Implantable device formed from polymer blends having modified molecular structures |
| 08/24/2007 | CA2568981A1 Integrase-derived hiv-inhibiting agents |
| 08/24/2007 | CA2537669A1 Inhibitors of nucleoside phosphorylases and nucleosidases for treating cancer |
| 08/23/2007 | WO2007095632A1 Crystalline forms of (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methol]piperidin-3-ol |
| 08/23/2007 | WO2007095628A1 Pyrazoloquinolones are potent parp inhibitors |
| 08/23/2007 | WO2007095618A2 Benzo-fused heterocycle sulfamide derivatives for the treatment of migraine |
| 08/23/2007 | WO2007095617A1 Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction |
| 08/23/2007 | WO2007095615A2 Use of benzo-heteroaryl sulfamide derivatives for the treatmentof pain |
| 08/23/2007 | WO2007095613A2 Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents |
| 08/23/2007 | WO2007095609A2 Use of benzo-heteroaryl sulfamide derivatives for the treatment of mania and bipolar disorder |
| 08/23/2007 | WO2007095607A1 Use of benzo-heteroaryl sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| 08/23/2007 | WO2007095606A1 Use of benzo-heteroaryl sulfamide derivatives for the treatment of depression |
| 08/23/2007 | WO2007095588A1 Pi-3 kinase inhibitors and methods of their use |
| 08/23/2007 | WO2007095513A1 Tetrahydr0-2h-indaz0le derivatives for use as cannabinoid modulators |
| 08/23/2007 | WO2007095424A1 Novel tricyclic dihydropyrazines as potassium channel openers |
| 08/23/2007 | WO2007095423A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators |
| 08/23/2007 | WO2007095383A2 Prodrugs |
| 08/23/2007 | WO2007095316A2 Compositions and methods for oligonucleotide formulations |
| 08/23/2007 | WO2007095223A2 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases |
| 08/23/2007 | WO2007095218A1 Intravenous antiviral treatments |
| 08/23/2007 | WO2007095156A2 Taste masking of aerosolized fluoroquinolones |
| 08/23/2007 | WO2007095147A2 Adhesive preparation comprising sufentanil and methods of using the same |
| 08/23/2007 | WO2007095124A2 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors |
| 08/23/2007 | WO2007095043A2 Pharmaceutical formulations |
| 08/23/2007 | WO2007095041A2 Pharmaceutical formulations |
| 08/23/2007 | WO2007095024A1 Metabotropic glutamate receptor-potentiating γsoindolones |
| 08/23/2007 | WO2007094718A1 Radioligands for the 5 -ht1b receptor |
| 08/23/2007 | WO2007094694A1 Use of 5h-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders |
| 08/23/2007 | WO2007094669A2 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation |
| 08/23/2007 | WO2007094605A1 Topical preparation composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases |
| 08/23/2007 | WO2007094600A1 A composition comprising 4-carbon dicarboxylic acids for improvement of memory function |
| 08/23/2007 | WO2007094548A2 Berberrubine derivatives having antifungal activities |
| 08/23/2007 | WO2007094513A2 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |